Tatiana Mouravskaia
Infectious Disease · South Orange, NJNPI 1851481857
Payments from drug & device makers
Across 149 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$605
- Merck$448
- Gilead$315
- Johnson & Johnson$309
- Insmed, Inc.$225
- Janssen Products, LP$170
- plus $543 from 13 others
What the payments were for
- Food & beverage$2,43293%
- Education$1827%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 44 | $605 |
| Merck | 24 | $448 |
| Gilead | 17 | $315 |
| Johnson & Johnson | 19 | $309 |
| Insmed, Inc. | 7 | $225 |
| Janssen Products, LP | 2 | $170 |
| AbbVie(2 entities) | 7 | $102 |
| Theratechnologies Inc. | 6 | $80 |
| Melinta Therapeutics, LLC | 5 | $70 |
| Paratek Pharmaceuticals, Inc. | 4 | $56 |
| Ferring Pharmaceuticals Inc. | 3 | $47 |
| Smith+Nephew | 2 | $42 |
| Shionogi Inc | 2 | $37 |
| Genentech USA, Inc. | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Aroa Biosurgery Incorporated | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arikayce$133
How this compares
$2,614 in reported general payments places this provider in the 70th percentile of 334 infectious disease providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 12 | $1,923 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in South Orange
- Jihad SlimNewark$6.7M
- Ronald NahassHillsborough$6.1M
- Bindu BalaniHackensack$4.9M
- Suraj SaggarEnglewood$2.9M
- Christopher LucastiSomers Point$2.8M
- Edward LiuNeptune$2.6M
- Keith GottesdienerRahway$2.1M
- Amna YaqubFlemington$1.4M
- Shobha SwaminathanNewark$1.4M
- Mohamed RabbatPaterson$760K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.